Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Am J Pathol ; 181(3): 1056-68, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22796434

ABSTRACT

ADAMTS5 is a member of the A Disintegrin-like And Metalloproteinase with ThromboSpondin motifs (ADAMTS) family of secreted metalloproteinases with multiple proteoglycan substrates. Although well characterized for its role in cartilage degradation and arthritis, how it influences cancer remains unclear. We have previously shown that the first thrombospondin type 1 repeat (TSR1, the central TSR) but not TSR2 (the C-terminal TSR) of ADAMTS5 is anti-angiogenic in vitro. Coupled with previous reports that ADAMTS5 expression is altered in several human cancers, we hypothesized that this proteoglycanase may play an important role in cancer and angiogenesis. Here, we demonstrated that overexpression of full-length ADAMTS5 suppressed B16 melanoma growth in mice. The reduced tumor growth is correlated with diminished tumor angiogenesis, together with reduced tumor cell proliferation and increased tumor cell apoptosis. Catalytically active ADAMTS5 proteolytic fragment also suppressed angiogenesis in vitro. The catalytic activity of ADAMTS5 is dispensable for its anti-tumorigenic function, as the full-length active site mutant E411A presented similar tumor suppression activity. Domain mapping and mechanistic studies revealed that ADAMTS5 inhibits B16 tumorigenesis through its TSR1 by suppressing tumor angiogenesis, likely by down-regulating pro-angiogenic factors such as vascular endothelial growth factor (VEGF), placenta growth factor (PlGF), and platelet-derived endothelial growth factor (PD-ECGF) in the tumor milieu. This is the first report that ADAMTS5 is an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity.


Subject(s)
ADAM Proteins/metabolism , Angiogenesis Inhibitors/metabolism , Cell Transformation, Neoplastic/pathology , Metalloendopeptidases/metabolism , ADAM Proteins/chemistry , ADAMTS5 Protein , Animals , Apoptosis , Biocatalysis , Cell Line , Cell Proliferation , Down-Regulation , Humans , Melanoma, Experimental/blood supply , Melanoma, Experimental/pathology , Metalloendopeptidases/chemistry , Mice , Mice, Inbred C57BL , Neovascularization, Pathologic/enzymology , Protein Structure, Tertiary , Sequence Deletion
2.
Biochem Biophys Res Commun ; 371(2): 215-9, 2008 Jun 27.
Article in English | MEDLINE | ID: mdl-18433719

ABSTRACT

Angiogenesis is critical for tumour growth and metastasis where factors that regulate this process are potential targets for development of anti-cancer drugs. In this study, we show that the first TSR domain of the extracellular matrix protease ADAMTS5, unlike the second TSR, has anti-angiogenic activities where it inhibits endothelial cell tube formation on Matrigel, reduces cell proliferation and attachment, while promoting cell apoptosis and migration, all in a dose-dependent manner. Furthermore, it influences the architecture of endothelial cells by disrupting actin stress fibres and reducing focal adhesions, likely via suppressing RhoA activation. TSR1 of ADAMTS5 is therefore a novel anti-angiogenic peptide and could serve as a prototype for future development into anti-cancer drugs.


Subject(s)
ADAM Proteins/pharmacology , Angiogenesis Inhibitors/pharmacology , Endothelial Cells/drug effects , Peptides/pharmacology , ADAM Proteins/chemistry , ADAM Proteins/genetics , ADAMTS5 Protein , Angiogenesis Inhibitors/chemistry , Angiogenesis Inhibitors/genetics , Apoptosis , Cell Adhesion/drug effects , Cell Movement/drug effects , Collagen/metabolism , Drug Combinations , Endothelial Cells/metabolism , Endothelial Cells/ultrastructure , Humans , Laminin/metabolism , Neovascularization, Pathologic , Peptides/chemistry , Peptides/genetics , Protein Structure, Tertiary , Proteoglycans/metabolism , Stress Fibers/drug effects , Thrombospondin 1/chemistry , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Vascular Endothelial Growth Factor A/pharmacology
3.
J Neurosci ; 26(23): 6364-76, 2006 Jun 07.
Article in English | MEDLINE | ID: mdl-16763045

ABSTRACT

We show that desert hedgehog (dhh), a signaling molecule expressed by Schwann cells, is essential for the structural and functional integrity of the peripheral nerve. Dhh-null nerves display multiple abnormalities that affect myelinating and nonmyelinating Schwann cells, axons, and vasculature and immune cells. Myelinated fibers of these mice have a significantly increased (more than two times) number of Schmidt-Lanterman incisures (SLIs), and connexin 29, a molecular component of SLIs, is strongly upregulated. Crossing Dhh-null mice with myelin basic protein (MBP)-deficient shiverer mice, which also have increased SLI numbers, results in further increased SLIs, suggesting that Dhh and MBP control SLIs by different mechanisms. Unmyelinated fibers are also affected, containing many fewer axons per Schwann cell in transverse profiles, whereas the total number of unmyelinated axons is reduced by approximately one-third. In Dhh-null mice, the blood-nerve barrier is permeable and neutrophils and macrophage numbers are elevated, even in uninjured nerves. Dhh-null nerves also lack the largest-diameter myelinated fibers, have elevated numbers of degenerating myelinated axons, and contain regenerating fibers. Transected dhh nerves degenerate faster than wild-type controls. This demonstrates that a single identified glial signal, Dhh, plays a critical role in controlling the integrity of peripheral nervous tissue, in line with its critical role in nerve sheath development (Parmantier et al., 1999). The complexity of the defects raises a number of important questions about the Dhh-dependent cell-cell signaling network in peripheral nerves.


Subject(s)
Neuroglia/metabolism , Sciatic Nerve/anatomy & histology , Sciatic Nerve/physiology , Signal Transduction , Trans-Activators/physiology , Aging/metabolism , Animals , Animals, Newborn/growth & development , Animals, Newborn/metabolism , Axons , Capillary Permeability , Cell Count , Cell Size , Connexins/genetics , Connexins/metabolism , Hedgehog Proteins , Mice , Mice, Knockout , Motor Neurons/pathology , Myelin Sheath/pathology , Nerve Degeneration , Nerve Fibers, Myelinated/ultrastructure , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , RNA, Messenger/metabolism , Schwann Cells/pathology , Sciatic Nerve/blood supply , Sciatic Nerve/ultrastructure , Trans-Activators/deficiency , Trans-Activators/genetics , Trans-Activators/metabolism , Up-Regulation
4.
SLAS Technol ; 22(4): 413-424, 2017 08.
Article in English | MEDLINE | ID: mdl-27899700

ABSTRACT

Advances in mechanobiology have suggested that physiological and pathological angiogenesis may be differentiated based on the ways in which the cells interact with the extracellular matrix (ECM) that exhibits partially different mechanical properties. This warrants investigating the regulation of ECM stiffness on cell behavior using angiogenesis assays. In this article, we report the application of the technique of active manipulation of ECM stiffness to study in vitro angiogenic sprouting of human microvascular endothelial cells (HMVECs) in a microfluidic device. Magnetic beads were embedded in the ECM through bioconjugation (between the streptavidin-coated beads and collagen fibers) in order to create a pretension in the ECM when under the influence of an external magnetic field. The advantage of using this magneto-microfluidic system is that the resulting change in the local deformability of the collagen fibers is only apparent to a cell at the pericellular level near the site of an embedded bead, while the global intrinsic material properties of the ECM remain unchanged. The results demonstrate that this system represents an effective tool for inducing noninvasively an external force on cells through the ECM, and suggest the possibility of creating desired stiffness gradients in the ECM for manipulating cell behavior in vitro.


Subject(s)
Collagen Type I/metabolism , Endothelial Cells/physiology , Extracellular Matrix/chemistry , Lab-On-A-Chip Devices , Magnetics , Mechanical Phenomena , Microfluidics/methods , Cells, Cultured , Humans
5.
Sci Rep ; 4: 4031, 2014 Feb 07.
Article in English | MEDLINE | ID: mdl-24504253

ABSTRACT

Delta-like 4 (Dll4), a membrane-bound Notch ligand, plays a fundamental role in vascular development and angiogenesis. Dll4 is highly expressed in capillary endothelial tip cells and is involved in suppressing neighboring stalk cells to become tip cells during angiogenesis. Dll4-Notch signaling is mediated either by direct cell-cell contact or by Dll4-containing exosomes from a distance. However, whether Dll4-containing exosomes influence tip cells of existing capillaries is unknown. Using a 3D microfluidic device and time-lapse confocal microscopy, we show here for the first time that Dll4-containing exosomes causes tip cells to lose their filopodia and trigger capillary sprout retraction in collagen matrix. We demonstrate that Dll4 exosomes can freely travel through 3D collagen matrix and transfer Dll4 protein to distant tip cells. Upon reaching endothelial sprout, it causes filopodia and tip cell retraction. Continuous application of Dll4 exosomes from a distance lead to significant reduction of sprout formation. This effect correlates with Notch signaling activation upon Dll4-containing exosome interaction with recipient endothelial cells. Furthermore, we show that Dll4-containing exosomes increase endothelial cell motility while suppressing their proliferation. These data revealed novel functions of Dll4 in angiogenesis through exosomes.


Subject(s)
Capillaries/growth & development , Endothelial Cells/metabolism , Exosomes/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Adaptor Proteins, Signal Transducing , Calcium-Binding Proteins , Cell Line, Tumor , Cell Movement , Cell Proliferation , Endothelial Cells/cytology , Humans , Image Processing, Computer-Assisted , Intercellular Signaling Peptides and Proteins/biosynthesis , Microfluidic Analytical Techniques , Microscopy, Electron, Transmission , Neovascularization, Physiologic , Pseudopodia/metabolism , Receptors, Notch/biosynthesis , Receptors, Notch/metabolism , Signal Transduction/physiology , Vascular Endothelial Growth Factor A/metabolism , Vascular Endothelial Growth Factor Receptor-1/biosynthesis , Vascular Endothelial Growth Factor Receptor-2/biosynthesis
6.
Cancer Microenviron ; 5(3): 323-32, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22585423

ABSTRACT

Cancer is a complex organ whose behavior is not only influenced by genetic and epigenetic changes in cancer cells but also by stromal cells, local extracellular matrix and specific tissue architecture. Intercellular communications within the cancer microenvironment are critical to coordinate the assembly of multiple cell types for an amalgamated form and function of a cancer. Exosomes are small membrane vesicles with an endosome origin that are released by cells into the extracellular environment. They carry a cargo of proteins, lipids, and nucleic acids and transfer their cargo to recipient cells and altering the recipient cells' biochemical composition, signaling pathways, and gene regulation. Exosomes can thus serve as extracellular messengers mediating cell-cell communication. Both cancer cells and stromal cells release exosomes not only into the cancer microenvironment but also into the circulation. In this review, we summarize the research done so far on cancer-derived exosomes and assess their roles as extracellular messengers facilitating cancer progression and metastasis.

7.
J Neurobiol ; 66(3): 243-55, 2006 Feb 15.
Article in English | MEDLINE | ID: mdl-16329124

ABSTRACT

Hedgehog proteins are important in the development of the nervous system. As Desert hedgehog (Dhh) is involved in the development of peripheral nerves and is expressed in adult nerves, it may play a role in the maintenance of adult nerves and degeneration and regeneration after injury. We firstly investigated the Dhh-receptors, which are expressed in mouse adult nerves. The Dhh receptor patched(ptc)2 was detected in adult sciatic nerves using RT-PCR, however, ptc1 was undetectable under the same experimental condition. Using RT-PCR in purified cultures of mouse Schwann cells and fibroblasts, we found ptc2 mRNA in Schwann cells, and at much lower levels, in fibroblasts. By immunohistochemistry, Ptc2 protein was seen on unmyelinated nerve fibers. Then we induced crush injury to the sciatic nerves of wild-type (WT) and dhh-null mice and the distal stumps of injured nerves were analyzed morphologically at different time points and expression of dhh and related receptors was also measured by RT-PCR in WT mice. In dhh-null mice, degeneration of myelinated fibers was more severe than in WT mice. Furthermore, in regenerated nerves of dhh-null mice, minifascicular formation was even more extensive than in dhh-null intact nerves. Both dhh and ptc2 mRNA levels were down-regulated during the degenerative phase postinjury in WT mice, while levels rose again during the phase of nerve regeneration. These results suggest that the Dhh-Ptc2 signaling pathway may be involved in the maintenance of adult nerves and may be one of the factors that directly or indirectly determines the response of peripheral nerves to injury.


Subject(s)
Nerve Regeneration/physiology , Receptors, Cell Surface/biosynthesis , Sciatic Nerve/metabolism , Wallerian Degeneration/metabolism , Animals , Female , Immunohistochemistry , In Situ Hybridization , Mice , Nerve Crush , Patched Receptors , Patched-1 Receptor , Patched-2 Receptor , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction
8.
Mol Cell Neurosci ; 23(1): 13-27, 2003 May.
Article in English | MEDLINE | ID: mdl-12799134

ABSTRACT

We investigated the role of Krox-20 (Egr2), a transcription factor that regulates myelination, in controlling the myelin-associated protein periaxin. In developing Schwann cells, periaxin immunoreactivity appeared at least 2 days before Krox-20-immunopositive nuclei. Consistent with this, in Krox-20 null mice periaxin was upregulated on schedule, albeit to a lower level. In culture Krox-20 and periaxin were upregulated by cAMP as expected for myelin genes. Only those cells with the highest periaxin levels also expressed Krox-20, while other periaxin-positive cells remained Krox-20-negative. Furthermore, cAMP elevated periaxin even in Krox-20 null cells. We also found that in culture enforced Krox-20 expression induced expression of periaxin mRNA and protein in the absence of cAMP elevating agents, and that this induction was inhibited by the co-repressor NAB2. These findings reveal a dual mechanism for periaxin regulation and suggest that the role of Krox-20 is to amplify an earlier Krox-20-independent activation of the periaxin gene. Thus the axonal signals responsible for myelination are only partially transduced in Schwann cells by mechanisms that depend on Krox-20.


Subject(s)
DNA-Binding Proteins/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Myelin Sheath/metabolism , Neoplasm Proteins , Schwann Cells/metabolism , Signal Transduction/physiology , Transcription Factors/metabolism , Animals , Cells, Cultured , Cyclic AMP/metabolism , DNA-Binding Proteins/genetics , Early Growth Response Protein 2 , Gene Expression Regulation, Developmental/physiology , Mice , Mice, Knockout , Mutagenesis/physiology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Repressor Proteins/genetics , Repressor Proteins/metabolism , Schwann Cells/cytology , Sciatic Nerve/cytology , Sciatic Nerve/growth & development , Sciatic Nerve/physiology , Transcription Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL